dc.contributor.author | Connolly, Deirdre | en |
dc.contributor.author | Smith, Susan | en |
dc.date.accessioned | 2022-02-17T13:31:18Z | |
dc.date.available | 2022-02-17T13:31:18Z | |
dc.date.issued | 2022 | en |
dc.date.submitted | 2022 | en |
dc.identifier.citation | Gillespie P, Hobbins A, O?Toole L, Connolly D, Boland F, Smith, S, Cost-effectiveness of an occupational therapy-led self-management support programme for multimorbidity in primary care, Family Practice, 2022 | en |
dc.identifier.other | Y | en |
dc.identifier.uri | http://hdl.handle.net/2262/98123 | |
dc.description | PUBLISHED | en |
dc.description.abstract | Background
Multimorbidity is a major public health concern. Complex interventions, incorporating individualized care plans, may be appropriate for patients with multimorbidity given their individualized and variable needs. There is a dearth of evidence on the cost-effectiveness of complex multimorbidity interventions.
Objective
This study examines the cost-effectiveness of a 6-week occupational therapy-led self-management support programme (OPTIMAL) for adults with multimorbidity.
Methods
Economic evaluation, from a healthcare perspective, was conducted alongside a randomized controlled trial of 149 adults with multimorbidity. Intervention was the OPTIMAL programme with a comparison of usual primary care. Incremental costs, quality-adjusted life years (QALYs) gained, and expected cost-effectiveness were estimated at 6 months and uncertainty was explored using cost-effectiveness acceptability curves.
Results
The intervention was associated with a mean improvement in QALYs gained of 0.031 per patient (P-value: 0.063; 95% confidence intervals [CIs]: −0.002 to 0.063) and a mean reduction in total costs of €2,548 (P-value: 0.114; 95% CIs: −5,606 to 509) per patient. At cost-effectiveness threshold values of €20,000 and €45,000 per QALY, the probability of the intervention being cost-effective was estimated to be 0.951 and 0.958, respectively. The results remained consistent across all subgroups examined.
Conclusions
This study adds to the limited evidence base on the cost-effectiveness of complex interventions for multimorbidity, and highlights the potential for the OPTIMAL programme to be cost-effective. Further studies are warranted to explore the clinical and cost-effectiveness of complex interventions for the multimorbidity patient population, and for subgroups within it.
Trial registration
Trial number: ISRCTN67235963. | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Family Practice | en |
dc.rights | Y | en |
dc.subject | Multimorbidity | en |
dc.subject | Complex Interventions | en |
dc.subject | Cost Effectiveness | en |
dc.title | Cost-effectiveness of an occupational therapy-led self-management support programme for multimorbidity in primary care | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/connoldm | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/susmith | en |
dc.identifier.rssinternalid | 237899 | en |
dc.rights.ecaccessrights | openAccess | |
dc.relation.doi | https://doi.org/10.1093/fampra/cmac006 | en |
dc.identifier.handle | http://hdl.handle.net/2262/98123 | en |
dc.relation.cites | Cites | en |
dc.relation.cites | Cites | en |
dc.subject.TCDTheme | Ageing | en |
dc.subject.TCDTheme | Inclusive Society | en |
dc.subject.TCDTag | COST-EFFECTIVENESS ANALYSIS | en |
dc.subject.TCDTag | Chronic disease self-management | en |
dc.subject.TCDTag | Health-related Quality of Life | en |
dc.subject.TCDTag | Occupational Therapy Primary Care | en |
dc.identifier.rssuri | https://doi.org/10.1093/fampra/cmac006 | en |
dc.relation.handle | http://hdl.handle.net/2262/98123 | en |
dc.identifier.orcid_id | 0000-0001-8539-8123 | en |
dc.subject.darat_impairment | Chronic Health Condition | en |
dc.subject.darat_thematic | Community | en |
dc.subject.darat_thematic | Health | en |
dc.status.accessible | N | en |
dc.contributor.sponsor | Health Research Board (HRB) | en |
dc.contributor.sponsorGrantNumber | HPF-2015-972 | en |